🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yuanjie Liang

Novo Nordisk (United States)

ORCID: 0000-0003-4566-0865
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Comparative effectiveness of GLP-1 RAs and other glucose-lowering therapies among Medicare Advantage beneficiaries with T2D and ASCVD”.

Comparative effectiveness of GLP-1 RAs and other glucose-lowering therapies among Medicare Advantage beneficiaries with T2D and ASCVD

Current Medical Research and Opinion(2025)10.1080/03007995.2025.2577762
N/A
0DataRank · unranked
1 citations

Yuanjie Liang, Lin Xie, Cynthia Gutierrez, Joanna Harton, Chalak Muhammad +3 more